The global metabolic disorder therapeutics market size is expected to reach USD 88.93 billion by 2025, according to a new report by Grand View Research, Inc. The market is anticipated to witness a CAGR of 7.56% during the estimated period. Rising incidences of diabetes, obesity, and hypercholesterolemia are expected to drive the market growth. It is estimated that by 2040, about 1 person in 11 people worldwide is likely to suffer from one of the aforementioned diseases.
Researchers
estimate that the prevalence of metabolic diseases like obesity and diabetes is
expected to double in the coming 2 decades, mainly in U.S. and Asian and Latin
American countries. This, in turn, will help boost the overall market growth in
the year to come. Furthermore, with better economic stability in developing
countries, demand for novel therapeutics for one-time treatment has increased.
This has made major companies in the global market to invest heavily in R&D
to develop innovative therapy options. All these factors will contribute to the
development of the market.
Full Research Report On Metabolic Disorder Therapeutics Market Visit Here:
https://www.grandviewresearch.com/industry-analysis/metabolic-disorder-therapeutics-market
Metabolic Disorder
Therapeutics Market Report Highlights
- Diabetes segment led the
metabolic disorder therapeutics market in 2017, in terms of revenue
generation,owing to higher prevalence and drug usage
- Obesity segment is expected
to register a CAGR of 9.27% over the forecast period owing to increasing
prevalence as a result of sedentary lifestyle changes
- Drug therapy was the
most-preferred therapy due to its high reliability proven success and
availability of various types of drugs to treat metabolic diseases
- The segment is expected to
maintain its dominance even during the forecast years due to the
introduction of smart technology to deliver antidiabetic drug on a
regulated basis
- Key companies in this market
are Novo Nordisk A/S;Sanofi S.A.; BoehringerIngelheim GmbH; Eli Lilly and
Company; Merck KgaA; Amgen, Inc.; AstraZeneca PLC; Actelion
Pharmaceuticals Ltd.; Shire PLC; AbbVie, Inc.;Biocon
Ltd.;BioMarinPharmaceutical, Inc.; Bristol-Myers Squibb Company; Cipla,
Inc.; and CymaBay Therapeutics, Inc.
- Most of these companies are
focusing on strategies, such as collaborations, expansion of product
portfolios, and M&A to maintain their industry position
- Oral route of administration
was the key revenue-generating segment in 2017owing to its benefits, such
as high reliability and ease of administration
- North America was the
largest regional market in 2017 and will maintain the trend in future due
to the presence of key companies and rising cases of diabetes and obesity
Request a Sample Copy of the Report @
https://www.grandviewresearch.com/industry-analysis/metabolic-disorder-therapeutics-market/request/rs1
Metabolic Disorder
Therapeutics Market Segmentation
Grand View Research has segmented
the global metabolic disorder therapeutics market on the basis of disease,
therapy type, route of administration, and region:
Metabolic Disorder
Therapeutics Disease Outlook (Revenue, USD Billion, 2014 - 2025)
- Lysosomal Storage Diseases
- Gaucher’s Disease
- Metachromatic Leukodystrophy
- Hurler - Scheie
- Sanfilipo A
- Others
- Diabetes
- Obesity
- Inherited Metabolic
Disorders
- Hypercholesterolemia
Metabolic
Disorder Therapy Type Outlook (Revenue, USD Billion, 2014 - 2025)
- Enzyme Replacement Therapy
- Cellular Transplantation
- Small Molecule Based Therapy
- Substrate Reduction Therapy
- Gene Therapy
- Drug Therapy
Metabolic Disorder
Therapeutics Route of Administration Outlook (Revenue, USD Billion, 2014 -
2025)
- Oral
- Parenteral
- Others
Metabolic Disorder
Therapeutics Regional Outlook (Revenue, USD Billion, 2014 - 2025)
- North America
- U.S.
- Canada
- Europe
- Germany
- U.K.
- Asia Pacific
- Japan
- China
- Latin America
- Brazil
- Middle East & Africa
- South Africa
About Grand View Research
Grand
View Research, Inc. is a U.S. based market research and consulting company, registered
in the State of California and headquartered in San Francisco. The company
provides syndicated research reports, customized research reports, and
consulting services. To help clients make informed business decisions, we offer
market intelligence studies ensuring relevant and fact-based research across a
range of industries, from technology to chemicals, materials and healthcare.
For more info visit @ https://www.grandviewresearch.com
No comments:
Post a Comment